Search Details

Word: revlimid (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

SU2C is not the only independent group shaking things up. The Multiple Myeloma Research Foundation used a pay-for-results funding model that has more to do with Silicon Valley than Big Pharma to support research that in four years got four new treatments to patients--Thalomid, Velcade, Revlimid and Doxil. That's about six years faster than the decade it usually takes for such drug development and rollout. Multiple myeloma is a rare cancer of the bone marrow that sickens about 20,000 Americans each year--precisely the uncommon form of the disease that often falls into the research...

Author: /time Magazine | Title: He Won His Battle With Cancer | 9/4/2008 | See Source »

| 1 |